2-DG manufactured by Dr. Reddy’s has a purity of 99.5% and is being sold commercially under the brand name 2DG, the Hyderabad-based pharma major said.
‘2-deoxy-D-glucose (2-DG) for treatment of Covid-19 can be administered only upon prescription and under the supervision of a qualified physician.’
The maximum retail price (MRP) of each sachet has been fixed at Rs. 990,with a subsidized rate offered to government institutions. Enquiries for 2DGTMcan be sent to 2DG@drreddys.com.
2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defense Research and Development Organization (DRDO), in collaboration with Dr. Reddy’s.2-DG is an oral drug.
It can be administered only upon prescription and under the supervision of a qualified physician to hospitalized moderate to severe Covid-19 patients as an adjunct therapy to the existing standard of care.
Emergency use approval for anti-Covid-19 therapeutic application of the drug was granted on May 1, 2021.
“We are pleased to have worked closely with our long-term industry partner Dr. Reddy’s Laboratories, Hyderabad, for testing 2-DG as therapeutic application in treatment of Covid-19 patients. DRDO has been contributing in fight against Covid-19 pandemic with its spin off technologies,” said Dr. G. Satheesh Reddy, Secretary Department of Defense (R&D) and Chairman, DRDO.
“2-DG is yet another addition to our Covid-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and includes a vaccine. We are extremely pleased to have partnered with DRDO in our collective fight against the Covid-19 pandemic,” said Satish Reddy, Chairman, Dr. Reddy’s.
Source: IANS
